Welcome, Guest
Username: Password: Remember me
The Company
  • Page:
  • 1

TOPIC: Hedrick presents in NY on February 15th

Hedrick presents in NY on February 15th 14 Feb 2017 06:36 #8813

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3299
  • Thank you received: 1110


Agenda below-


Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that it will present at the 2nd Annual Disruptive Growth & Healthcare Conference at 11:15 AM Eastern Time (8:15 AM Pacific Time) on Wednesday, February 15, 2017. The presentation will take place in the Track 3 - Nolita room at the Convene in New York City. Dr. Marc Hedrick, CEO and President of Cytori Therapeutics, will provide an update on current corporate activities and recent developments. For those interested in attending, please visit www.DisruptNYC.com for more information.

Attachments:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Hedrick presents in NY on February 15th 15 Feb 2017 07:10 #8826

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3299
  • Thank you received: 1110
The powerpoint presentation in PDF format has been released already and looks quite interesting.

I already took out the first two images for the

1. pipeline- from which the bone repair clinic has been removed :grin: -but not for long I presume.



2. More detail on the Habeo clinic and which patients/disorders are targeted..



Of course the full PDF can be reviewed also and is attached..

File Attachment:

File Name: NY-FEB-2017.pdf
File Size: 3,668 KB
Attachments:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Hedrick presents in NY on February 15th 15 Feb 2017 07:40 #8827

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1280
  • Thank you received: 18
Fas, I find it interesting that for scleroderma, the Company is apparently planning for an off-the-shelf drug to replace or supplement the HABEO therapy - am I interpreting that correctly and does it make sense to you??

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 08:08 #8828

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
Right. So a backup if scleroderma Phase 3 failure or potential for ongoing improvements if scleroderma Phase 3 approval. Only time will tell. I also find it interesting that it's not under Habeo, but rather their new TM.

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 08:42 #8829

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3299
  • Thank you received: 1110
No- I do not think it is a back-up.

From the time (5 years ago) when I looked closely at the disorder (and related disorders) , I remember that the more "serious" forms effect different body parts and organs- mainly the lungs i.e. form fibrotic tissue around the lungs etc, which slowly but surely cut off the oxygen supply through blockage of the blood flow.

Assuming that the liposomal technology is thought to keep the "vesicles" at the site of (chronic) injury its better to use the vesicles than the cells obviously since the cells would wonder thru the whole body and be less effective.

Anyway- I will look at my "old" write-up and put it back online today or tomorrow.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Hedrick presents in NY on February 15th 15 Feb 2017 08:53 #8830

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
Interesting, Fas -- your theory would explain why it's not under the hand treatment franchise.

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 08:59 #8831

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1280
  • Thank you received: 18
Thanks - I assume that we will learn more about this question in today's presentation.

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 09:13 #8833

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 789
  • Thank you received: 103
FAS

In a recent email from Tiago, it does not appear to be a back up.

It is clear that CYTX needs a partner-able platform to sustain and grow. Celution system along is not enough to grow the company. Now, we are a drug company.

Rodney Strong/the Old Chuck

Time for parabolic upward move?!

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 09:28 #8834

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2768
  • Thank you received: 199
Fas
That was always a concern for me with the IV approach.
Now that they may be able to target specific organs the IV approach has legs imho (assuming they can make do what they want it to do)
This would essentially mean they would "own" the scleroderma market and turn it into a manageable chronic type disease vs a progressive, then fatal one.
Retreatment has been a Hedrick topic for some time now.

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 09:31 #8835

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2768
  • Thank you received: 199
franshei

***Rodney Strong/the Old Chuck***
Most definitely

***Time for parabolic upward move?!***
I hope not.
I do like Riley's year end $5+ though

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 15 Feb 2017 09:46 #8836

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1280
  • Thank you received: 18
Franshei/HF, thanks for the comparison to the "Old Chuck" - he had some very positive and excellent posts before the old Yahoo MB collapsed.

Please Log in or Create an account to join the conversation.

Hedrick presents in NY on February 15th 21 Feb 2017 09:21 #8887

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 789
  • Thank you received: 103
FAS

This is a puzzle:

Liposomal doxo and liposomal docetaxel are all lyophilized (freeze dry) products) they would be reconstituted with normal saline, before iv injection. The reconstituted product would represents liposomal encapsulation of the drugs (before freeze dry and then after reconstitution).

For Hedrick's cell free, off the shelf regenerative medicine (druggable form, probably by iv route), what active ingredients would they be, if the encapsulated drug product would be lyophilized.

Alternatively, there could be two clinical vials (as in the case of mitoextra that I worked on, using Jannssen's exceptients ) - one is the biological active ingredient/s and the other vial is the liposomal vehicle (with tissue or organ targetting properties); they would be mixed before injection.

Puzzling for me.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 1.159 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites